FDA/CDC
FDA/CDC
FDA okays emergency use for Impella RP in COVID-19 right heart failure
FDA/CDC
FDA okays first tau radiotracer to aid Alzheimer’s disease diagnosis
This is the first drug approved for imaging tau pathology, one of the two neuropathologic hallmarks of Alzheimer’s disease.
FDA/CDC
Remdesivir shortens COVID-19 time to recovery in published study
The NIAID reported initial promising results from the study earlier this month, which prompted the FDA to issue an emergency use authorization for...
News from the FDA/CDC
FDA tightens requirements for COVID-19 antibody tests
The U.S. Food and Drug Administration is tightening requirements for companies that develop COVID-19 antibody tests in an effort to combat fraud...
FDA/CDC
FDA authorizes emergency use of remdesivir for COVID-19
The designation means remdesivir can be distributed in the United States and administered intravenously by healthcare providers, as appropriate,...
FDA/CDC
FDA reiterates hydroxychloroquine limitations for COVID-19
An FDA Safety Communication restates that hydroxychloroquine and chloroquine are only for hospitalized COVID-19 patients who can’t enter a trial...
FDA/CDC
FDA approves emergency use of saliva test to detect COVID-19
“We can significantly increase the number of people tested each and every day as self-collection of saliva is quicker and more scalable than swab...
FDA/CDC
Suicide increased 35% during 1999-2018 in the U.S.
Rates were significantly higher in rural areas than urban ones in 2018.
FDA/CDC
CDC issues new return-to-work guidelines
Essential workers must take their temperature before work, wear a facial mask at all times, and practice social distancing when at work.
Latest News
FDA grants emergency authorization for first rapid antibody test for COVID-19
Labeling for the new antibody test indicates that the results should not be used as the sole basis to diagnose or exclude SARS-CoV-2 infection.
News from the FDA/CDC
FDA okays emergency use of convalescent plasma for seriously ill COVID-19 patients
“It’s crucial that data be captured for every patient so that we really understand what safety and effectiveness looks like on as close to a real-...